reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure. [https://nauticusrobotics.com/]Cautionary Language Regarding Forward- Looking StatementsThis press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Act"), and are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Act as well as p ...

Group 1 - Shutterstock expresses satisfaction with the UK Competition and Markets Authority's (CMA) provisional decision regarding the merger with Getty Images, indicating no expected competition issues in the global stock content market [1] - The company disagrees with the CMA's finding that the merger may lead to a 'substantial lessening of competition' in the UK Editorial market, arguing that the analysis does not accurately reflect the UK market dynamics and customer alternatives [1] - Shutterstock plans to engage constructively with the CMA and will respond to the interim report according to the CMA's timeline, while also cooperating with the U.S. Department of Justice in its review [1] Group 2 - Shutterstock is positioned as a provider of scalable creative and GenAI solutions, leveraging a global network of creators and advanced technology to enhance business effectiveness [1] - The company boasts one of the largest and most diverse collections of high-quality licensable assets, data, AI solutions, and full-service studio production capabilities [1]

Core Insights - Calvin Klein Fragrances has launched a new collection called euphoria elixirs, featuring three distinct parfum intense creations, with GRAMMY® Award-winning artist ROSALÃ A as the face of the campaign [1][2] - The euphoria elixirs are designed to explore themes of confidence, pleasure, and sensuality, with a focus on the key ingredient, vanilla, presented in three interpretations: magnetic elixir, bold elixir, and solar elixir [1][2] Product Details - The euphoria elixirs collection includes three scents: - **Magnetic Elixir**: A musky vanilla fragrance that combines Dancing Lady Orchid and ambrette absolute, designed to evoke effortless confidence and sensuality [1][2] - **Bold Elixir**: A woody vanilla scent featuring oakwood and smoky orchid, aimed at conveying intensity and depth [1][2] - **Solar Elixir**: A bright and joyful fragrance that pairs vanilla with mango, inspired by the blooming vanilla flower [1][2] - All three scents have an ultra-concentration of 28% or more, marking the highest fragrance concentration for Calvin Klein Fragrances [1][2] Packaging and Pricing - The packaging for the euphoria elixirs has been redesigned with vibrant colors: magnetic pink, bold purple, and solar yellow, reflecting youthful energy [1][2] - The euphoria elixirs will be available starting March 1, 2026, with pricing set at $129 for 100ml, $99 for 50ml, $79 for 30ml, and $36 for 10ml [1][2] Brand Background - Calvin Klein is a leading global fashion lifestyle brand founded in New York in 1968, with global retail sales of approximately $9 billion in 2024 [1][2] - Coty Inc., founded in Paris in 1904, is one of the largest beauty companies globally, with a diverse portfolio across fragrance, color cosmetics, and skin and body care [1][2]

AudioEye Sets Fourth Quarter and Full Year 2025 Earnings Call [Accessibility Statement] Skip NavigationTUCSON, Ariz., Feb. 19, 2026 /PRNewswire/ -- [AudioEye, Inc.](Nasdaq: AEYE) ("AudioEye" or the "Company"), the industry-leading digital accessibility company, will hold a conference call on Thursday, March 5, 2026 at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Financial results will be issued in a press release prior to the call.Audi ...

Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians dir ...

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping [Accessibility Statement] Skip NavigationFoundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene MappingSACRAMENTO, Calif., Feb. 19, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven biotechnology company advancing precision therapeutics in central nervous system (CNS) disorders and oncology, as well as solutions for ...

Core Viewpoint - IceCure Medical Ltd. has announced that Thomas Hospital in Alabama has installed the ProSense® system, making it the first hospital in the state to offer breast cancer cryoablation procedures, which are set to begin in the coming weeks [1]. Group 1: Company Developments - IceCure Medical specializes in minimally-invasive cryoablation technology aimed at destroying tumors through freezing, providing an alternative to surgical tumor removal [1]. - The ProSense® Cryoablation System is the first medical device to receive FDA marketing authorization for the local treatment of low-risk breast cancer in women aged 70 and above, including those unsuitable for surgical options [1]. - The installation of ProSense® at Thomas Hospital was funded by the Thomas Hospital Foundation, which aims to support access to advanced medical technology [1]. Group 2: Market Impact - The installation follows increased interest in ProSense® after its FDA clearance in October 2025 for treating low-risk breast cancer, indicating a potential rise in installations across other facilities [1]. - IceCure's Vice President of Sales noted that the hospital network's patient volume could lead to a significant number of eligible women benefiting from the ProSense® system as a minimally invasive treatment option [1]. Group 3: Technology Overview - ProSense® utilizes liquid nitrogen to create large lethal zones for effective tumor destruction in both benign and cancerous lesions, enhancing patient recovery and reducing surgical risks [1]. - The system's design allows for fast and convenient office-based procedures, making it a valuable addition to breast cancer treatment options [1].

Core Insights - Travelzoo reported a consolidated revenue of $22.5 million for Q4 2025, representing a 9% increase year-over-year from $20.7 million [1] - The company experienced a net loss of $19,000, or $0.00 per share, compared to a profit of $3.2 million, or $0.26 per share, in the prior-year period [1] - Non-GAAP operating profit was $0.9 million, excluding certain expenses, while GAAP operating income was $554,000 [1] Financial Performance - Revenue for Q4 2025 was $22.5 million, up 9% from $20.7 million year-over-year; in constant currencies, revenue was $22.1 million, up 7% [1] - North America segment revenue increased 6% year-over-year to $14.8 million, while Europe segment revenue rose 16% to $6.3 million [1] - Operating profit for North America was $1.5 million (10% of revenue), down from $4.6 million (33% of revenue) in the prior-year period [1] - Europe segment reported an operating loss of $1 million (16% of revenue), compared to an operating profit of $159,000 (3% of revenue) in the prior-year period [1] Membership and Marketing - The company invested significantly in acquiring new Club Members, leading to increased marketing costs that were expensed immediately [1] - Membership fees revenue is recognized ratably over a 12-month subscription period, impacting EPS negatively [1] - Travelzoo aims to leverage its global reach and relationships with travel suppliers to negotiate more offers for Club Members [1] Cash Flow and Balance Sheet - Cash flow from operations was $1.5 million, with cash, cash equivalents, and restricted cash totaling $10.8 million as of December 31, 2025 [1] - Deferred revenue increased due to the recognition of membership fees over the subscription period [1] Future Outlook - The company expects continued revenue growth in Q1 2026 and subsequent quarters as more Legacy Members transition to Club Members [1] - Profitability is anticipated to increase over time as recurring membership fees are recognized [1]

Core Viewpoint - American Public Education, Inc. (APEI) is scheduled to hold a conference call on March 12, 2026, to discuss its financial results for the fourth quarter and full year ended December 31, 2025 [1]. Company Overview - APEI provides online and campus-based postsecondary education to approximately 109,000 students [1]. - The company operates through its institutions: American Public University System (APUS), Rasmussen University, and Hondros College of Nursing [1]. - APUS serves around 88,700 adult learners globally and is recognized as a leading educator for active-duty military and veteran students [1]. - Rasmussen University, with a history of 125 years, serves approximately 15,900 students across 18 campuses in five states and online [1]. - Hondros College of Nursing focuses on pre-licensure nursing education and serves about 4,000 students, being the largest educator of PN (LPN) nurses in Ohio [1]. Financial Call Details - The conference call will take place at 5:00 PM Eastern Time, with a toll-free dial-in option available [1]. - A replay of the conference call will be accessible until March 26, 2026 [1].

systems and geointelligence pioneer with a 55-year+ story of world firsts and more than 450 missions, MDA Space is a global leader in communications satellites, Earth and space observation, and space exploration and infrastructure. The global MDA Space team of more than 3,800 space experts has the knowledge and know-how to turn an audacious customer vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since ...